The impact of testosterone, tibolone and black cohosh on purified mammary and placental 17β-hydroxysteroid dehydrogenase type 1

References

• Chlebowski RT, Anderson GL. Changing concepts: menopausal hormone therapy and breast cancer. J Natl Cancer Inst 2012;104:517–27
   PubMed Web of Science ®Google Scholar
• Formoso G, Perrone E, Maltoni S, et al. Short and long term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev 2012;2:CD008536
   Google Scholar
• de Gooyer ME, Deckers GH, Schoonen WG, et al. Receptor profiling and endocrine interactions of tibolone. Steroids 2003;68:21–30
   PubMed Web of Science ®Google Scholar
• Notelovitz M. Postmenopausal tibolone therapy: biologic principles and applied clinical practice. MedGenMed: Medscape General Medicine 2007;9:2
   PubMedGoogle Scholar
• Ziaei S, Moghasemi M, Faghihzadeh S. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women. Climacteric 2010;13:147–56
   PubMed Web of Science ®Google Scholar
• Labrie F, Belanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396–402
   PubMed Web of Science ®Google Scholar
• Graziottin A, Koochaki PE, Rodenberg CA, Dennerstein L. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. J Sex Med 2009;6:2143–53
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645–51
   PubMed Web of Science ®Google Scholar
• Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012;9:CD007244
   PubMedGoogle Scholar
• Jarry H, Harnischfeger G, Duker E. The endocrine effects of constituents of Cimicifuga racemosa. In vitro binding of constituents to estrogen receptors. Planta medica 1985:316–19
   Google Scholar
• Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661–70
   PubMed Web of Science ®Google Scholar
• Gaube F, Wolfl S, Pusch L, et al. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7. BMC Pharmacol 2007;7:11
   Google Scholar
• Kenemans P, van der Mooren MJ. Androgens and breast cancer risk. Gynecol Endocrinol 2012;28:46–9
   PubMed Web of Science ®Google Scholar
• Einbond LS, Soffritti M, Degli ED, et al. Chemopreventive potential of black cohosh on breast cancer in Sprague-Dawley rats. Anticancer Res 2012;32:21–30
   PubMed Web of Science ®Google Scholar
• Subramanian A, Salhab M, Mokbel K. Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res Treat 2008;111:191–202
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006;102:89–96
   PubMed Web of Science ®Google Scholar
• Desreux J, Kloosterboer H, Noel A, et al. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice. Gynecol Obstet Invest 2007;63:31–8
   PubMed Web of Science ®Google Scholar
• Raobaikady B, Day JM, Purohit A, et al. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites. J Steroid Biochem Mol Biol 2005;94:229–37
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. Tissue-selective effects of tibolone on the breast. Maturitas 2004 24;49:S5–15
   PubMed Web of Science ®Google Scholar
• van de Ven J, Donker GH, Sprong M, et al. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells. J Steroid Biochem Mol Biol 2002;81:237–47
   PubMed Web of Science ®Google Scholar
• Purohit A, Malini B, Hooymans C, Newman SP. Inhibition of oestrone sulphatase activity by tibolone and its metabolites. Horm Metab Res 2002;34:1–6
   PubMed Web of Science ®Google Scholar
• Chetrite G, Kloosterboer HJ, Pasqualini JR. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res 1997;17:135–40
   PubMed Web of Science ®Google Scholar
• Gotte M, Kalkhake K, Ploeger S, et al. Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro. J Steroid Biochem Mol Biol 2009;117:168–75
   PubMed Web of Science ®Google Scholar
• Stute P, Nisslein T, Gotte M, et al. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro. Maturitas 2007 20;57:382–91
   PubMed Web of Science ®Google Scholar
• Peltoketo H, Luu-The V, Simard J, Adamski J. 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 1999;23:1–11
   PubMed Web of Science ®Google Scholar
• Miettinen M, Mustonen M, Poutanen M, et al. 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat 1999;57:175–82
   PubMed Web of Science ®Google Scholar
• Ghersevich S, Poutanen M, Tapanainen J, Vihko R. Hormonal regulation of rat 17 beta-hydroxysteroid dehydrogenase type 1 in cultured rat granulosa cells: effects of recombinant follicle-stimulating hormone, estrogens, androgens, and epidermal growth factor. Endocrinology 1994;135:1963–71
   PubMed Web of Science ®Google Scholar
• Lewintre EJ, Orava M, Vihko R. Regulation of 17 beta-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor-alpha in choriocarcinoma cells. Endocrinology 1994;135:2629–34
   PubMed Web of Science ®Google Scholar
• Piao YS, Peltoketo H, Jouppila A, Vihko R. Retinoic acids increase 17 beta-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells. Endocrinology 1997;138:898–904
   PubMed Web of Science ®Google Scholar
• Ghersevich S, Akinola L, Kaminski T, et al. Activin-A, but not inhibin, regulates 17beta-hydroxysteroid dehydrogenase type 1 activity and expression in cultured rat granulosa cells. J Steroid Biochem Mol Biol 2000;73:203–10
   PubMed Web of Science ®Google Scholar
• Stute P, Gotte M, Kiesel L. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro. Breast Cancer Res Treat 2008;108:363–74
   PubMed Web of Science ®Google Scholar
• Soderqvist G, Olsson H, Wilking N, et al. Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives. J Steroid Biochem Mol Biol 1994;48:221–4
   PubMed Web of Science ®Google Scholar
• Stute P, Register TC, Blair RM, Cline JM. Effects of tibolone on estrogen biosynthesis in the mammary tissue of postmenopausal monkeys. Menopause 2006;13:232–40
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54
   Google Scholar
• Lin SX, Yang F, Jin JZ, et al. Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta. J Biol Chem 1992 15;267:16182–7
   Google Scholar
• Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985;6:103–12
   Web of Science ®Google Scholar
• Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models. Biometrical J 2008;3:346–63
   Google Scholar
• Sherbet DP, Guryev OL, Papari-Zareei M, et al. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells. Endocrinology 2009;150:4154–62
   PubMed Web of Science ®Google Scholar
• Khan N, Sharma KK, Andersson S, Auchus RJ. Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys 2004;429:50–9
   PubMed Web of Science ®Google Scholar
• Geoghegan KF, Song X, Hoth LR, et al. Unexpected mucin-type O-glycosylation and host-specific N-glycosylation of human recombinant interleukin-17A expressed in a human kidney cell line. Protein Expr Purif 2013;87:27–34
   PubMed Web of Science ®Google Scholar
• Lewis L. Human placental 17β-estradiol dehydrogenase: characterization and structural studies. Cancer Commission of Harvard University Publication No. 1448 1973
   Google Scholar
• Inaba N, Renk T, Daume E, Bohn H. Ectopic production of placenta-“specific” tissue proteins (PP5 and PP11) by malignant breast tumors. Arch Gynecol 1981;231:87–90
   PubMedGoogle Scholar
• de Gooyer ME, Oppers-Tiemissen HM, Leysen D, et al. Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 2003;68:235–43
   PubMed Web of Science ®Google Scholar
• Dimitrakakis C, Zhou J, Wang J, et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292–8
   PubMed Web of Science ®Google Scholar
• Zhou J, Ng S, Adesanya-Famuiya O, et al. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2000;14:1725–30
   PubMed Web of Science ®Google Scholar
• Hofling M, Lundstrom E, Azavedo E, et al. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. Climacteric 2007;10:155–63
   PubMed Web of Science ®Google Scholar
• Kenemans P, Bundred NJ, Foidart JM, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10:135–46
   PubMed Web of Science ®Google Scholar
• Rice S, Amon A, Whitehead SA. Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells. Maturitas 2007;56:359–67
   PubMed Web of Science ®Google Scholar
• Obi N, Chang-Claude J, Berger J, et al. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study. Cancer Epidemiol Biomarkers Prev 2009;18:2207–13
   PubMed Web of Science ®Google Scholar
• Henneicke-von Zepelin HH, Meden H, Kostev K, et al. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 2007;45:143–54
   PubMed Web of Science ®Google Scholar
• Hirschberg AL, Edlund M, Svane G, et al. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause 2007;14:89–96
   PubMed Web of Science ®Google Scholar
• Bonney RC, Reed MJ, Davidson K, et al. The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol 1983;19:727–39
   PubMed Web of Science ®Google Scholar
• Tait GH, Newton CJ, Reed MJ, James VH. Multiple forms of 17 beta-hydroxysteroid oxidoreductase in human breast tissue. J Mol Endocrinol 1989;2:71–80
   PubMed Web of Science ®Google Scholar